Anti-schizophrenia drug Cobenfy could treat Alzheimer's
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, USA, on Wednesday, December 27, 2023.…
pharmaceutical products
High-cost weight-loss drugs drive nutritional counseling to employers
Wegovy, Ozempic and Mounjaro weight loss medication packages. Image Alliance | fake images A few years ago, when Virta Health…
Walgreens (WBA) earnings in the first quarter of 2025
People walk up to a Walgreens pharmacy on March 9, 2023 in New York City. Leonardo Muñoz | Corbis News…
FDA Approves Eli Lilly's Zepbound Weight-Loss Drug for Sleep Apnea
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York, U.S., on Thursday, March…
Merck signs weight loss pills licensing agreement with Hansoh Pharma
Exterior view of the entrance to Merck headquarters on February 5, 2024 in Rahway, New Jersey. Spencer Platt | fake…
Eli Lilly's Zepbound Weight Loss Drug No Longer in Shortage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
UnitedHealth Group CEO Andrew Witty Addresses Death of Brian Thompson
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled “Hacking America's Health Care: Assessing Cyberattack's…
We want to increase our ownership of a portfolio stock that just increased its dividend.
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Eli Lilly Zepbound causes more weight loss than Novo Nordisk Wegovy: trial
A merged image shows an injectable pen of Zepbound, Eli Lilly's weight-loss drug, and boxes of Wegovy, made by Novo…
Our newest portfolio stocks pulled back from their recent 52-week high, so we're buying more
We are buying 300 shares of Bristol-Myers Squibb at approximately $58 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will…